STAA - STAAR Surgical Company

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
1.57B
Enterprise Value 3
1.48B
Trailing P/E
195.22
Forward P/E 1
130.15
PEG Ratio (5 yr expected) 1
6.58
Price/Sales (ttm)
11.00
Price/Book (mrq)
10.50
Enterprise Value/Revenue 3
10.41
Enterprise Value/EBITDA 6
104.64

Trading Information

Stock Price History

Beta (3Y Monthly) 2.33
52-Week Change 3-16.98%
S&P500 52-Week Change 313.40%
52 Week High 344.29
52 Week Low 321.70
50-Day Moving Average 328.70
200-Day Moving Average 328.92

Share Statistics

Avg Vol (3 month) 3327.16k
Avg Vol (10 day) 3462.3k
Shares Outstanding 544.61M
Float 29.04M
% Held by Insiders 10.93%
% Held by Institutions 191.09%
Shares Short (Oct 15, 2019) 43.18M
Short Ratio (Oct 15, 2019) 412.04
Short % of Float (Oct 15, 2019) 49.59%
Short % of Shares Outstanding (Oct 15, 2019) 47.13%
Shares Short (prior month Sep 13, 2019) 43.34M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 22/1
Last Split Date 3May 18, 1992

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 28, 2018
Most Recent Quarter (mrq)Sep 27, 2019

Profitability

Profit Margin 6.15%
Operating Margin (ttm)7.48%

Management Effectiveness

Return on Assets (ttm)3.74%
Return on Equity (ttm)6.30%

Income Statement

Revenue (ttm)142.49M
Revenue Per Share (ttm)3.21
Quarterly Revenue Growth (yoy)22.90%
Gross Profit (ttm)91.51M
EBITDA 14.18M
Net Income Avi to Common (ttm)8.77M
Diluted EPS (ttm)0.18
Quarterly Earnings Growth (yoy)63.70%

Balance Sheet

Total Cash (mrq)112.33M
Total Cash Per Share (mrq)2.52
Total Debt (mrq)10.36M
Total Debt/Equity (mrq)6.93
Current Ratio (mrq)5.50
Book Value Per Share (mrq)3.35

Cash Flow Statement

Operating Cash Flow (ttm)18.35M
Levered Free Cash Flow (ttm)6.61M